Lisa A. Lacasse: Urgent call to pass the MCED Act for multi-cancer detection
Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), shared a post on LinkedIn:
“Now is the time to act! Send a message to your members of Congress right now and urge them to pass this bill to lay the groundwork for Medicare to cover innovative multi-cancer early detection tests once they are FDA-approved and shown to have clinical benefit.”
Quoting American Cancer Society Cancer Action Network:
“URGENT: Congress has just days left to pass a year-end package. The package includes language based on the MCED Act, a bill that would make groundbreaking multi-cancer early detection screening tests more available.
We’ve never been this close to passing this bill. And it’s all thanks to the incredible work of ACS CAN advocates like you!
The final push! Send a message to your members of Congress right now and urge them to pass this bill to lay the groundwork for Medicare to cover innovative multi-cancer early detection tests once they are FDA-approved and shown to have clinical benefit.”
Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), has an impactful leadership in healthcare advocacy. Leading ACS CAN’s nationwide public policy advocacy agenda with her oversight of a dedicated team in Washington, D.C., she ensures effective advocacy efforts at the highest levels. Beyond her role at ACS CAN, Lacasse’s commitment to public health extends to serving on the board for the Campaign for Tobacco-Free Kids.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023